Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 18/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2763184 | 0.84 | MEN1 (0.54) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL13758232 | 0.83 | SMN1; SMN2 (0.53) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL15229953 | 0.83 | MEN1 (0.42) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL572448 | 0.78 | FDPS (0.47) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL3630928 | 0.77 | FDPS (0.41) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL4353565 | 0.76 | FDPS (0.31) | FDPS | |
| SCHEMBL3621826 | 0.74 | FDPS (0.43) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL15229909 | 0.74 | FDPS (0.43) | FDPSMEN1APAF1NPC1PLA2G1B | |
| SCHEMBL1905485 | 0.73 | FDPS (0.37) | FDPS | |
| SCHEMBL16445172 | 0.72 | FDPS (0.38) | FDPSMEN1APAF1NPC1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1685095-B1 | METHOD FOR THE PRODUCTION OF ORGANIC SALTS CONTAINING BIS(PERFLUOROALKYL)PHOSPHINATE ANIONS | MERCK PATENT GMBH (DE) | 2010-08-11 | — | — | EP | disclosed |
| US-7576242-B2 | N-Ethylpyridinium bis(pentafluoroethyl)phosphinate; reacting tris(perfluoroalkyl)phosphine oxide is reacted with an alcohol and an organic base; ionic liquids | MERCK PATENT GMBH (DE) | 2009-08-18 | — | — | US | disclosed |
| US-20070128515-A1 | Process for the preparation of organic salts containing bis(perfluoroalkyl) phosphinate anions | MERCK PATENT GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
| EP-1685095-A1 | METHOD FOR THE PRODUCTION OF ORGANIC SALTS CONTAINING BIS(PERFLUOROALKYL)PHOSPHINATE ANIONS | MERCK PATENT GmbH (DE) | 2006-08-02 | — | — | EP | disclosed |
| WO-2005049555-A1 | METHOD FOR THE PRODUCTION OF ORGANIC SALTS CONTAINING BIS(PERFLUOROALKYL)PHOSPHINATE ANIONS | MERCK PATENT GMBH (DE) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070128515-A1 | Process for the preparation of organic salts containing bis(perfluoroalkyl) phosphinate anions | PHOSPHO1, PFAS, PFKFB1 | FDPS 159/4885MEN1 2001/4885APAF1 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.